1-20644665-A-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032409.3(PINK1):c.952A>T(p.Met318Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000737 in 1,614,172 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00086 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00072 ( 1 hom. )
Consequence
PINK1
NM_032409.3 missense
NM_032409.3 missense
Scores
5
7
7
Clinical Significance
Conservation
PhyloP100: 8.04
Genes affected
PINK1 (HGNC:14581): (PTEN induced kinase 1) This gene encodes a serine/threonine protein kinase that localizes to mitochondria. It is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations in this gene cause one form of autosomal recessive early-onset Parkinson disease. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07187414).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PINK1 | NM_032409.3 | c.952A>T | p.Met318Leu | missense_variant | 4/8 | ENST00000321556.5 | NP_115785.1 | |
PINK1-AS | NR_046507.1 | n.3981+920T>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PINK1 | ENST00000321556.5 | c.952A>T | p.Met318Leu | missense_variant | 4/8 | 1 | NM_032409.3 | ENSP00000364204.3 | ||
PINK1 | ENST00000492302.1 | n.2040A>T | non_coding_transcript_exon_variant | 2/5 | 2 | |||||
PINK1-AS | ENST00000451424.1 | n.3981+920T>A | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000861 AC: 131AN: 152222Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
131
AN:
152222
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000900 AC: 226AN: 251094Hom.: 1 AF XY: 0.000847 AC XY: 115AN XY: 135776
GnomAD3 exomes
AF:
AC:
226
AN:
251094
Hom.:
AF XY:
AC XY:
115
AN XY:
135776
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000724 AC: 1058AN: 1461832Hom.: 1 Cov.: 31 AF XY: 0.000688 AC XY: 500AN XY: 727224
GnomAD4 exome
AF:
AC:
1058
AN:
1461832
Hom.:
Cov.:
31
AF XY:
AC XY:
500
AN XY:
727224
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000860 AC: 131AN: 152340Hom.: 0 Cov.: 33 AF XY: 0.000872 AC XY: 65AN XY: 74502
GnomAD4 genome
AF:
AC:
131
AN:
152340
Hom.:
Cov.:
33
AF XY:
AC XY:
65
AN XY:
74502
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
4
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
7
ExAC
AF:
AC:
124
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:5
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 17, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | PINK1: PM2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 26, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 16755580, 22118943, 15970950, 22644621, 18330912, 19351622, 16547921, 22243833, 27094865, 15596610, 21412950, 34426522, 27393345, 24660942, 30665447, 33921279, 35954270) - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Oct 04, 2023 | BS1 - |
Autosomal recessive early-onset Parkinson disease 6 Uncertain:5
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 26, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Centogene AG - the Rare Disease Company | Aug 27, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 25, 2022 | This sequence change replaces methionine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 318 of the PINK1 protein (p.Met318Leu). This variant is present in population databases (rs139226733, gnomAD 0.3%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individual(s) with in the heterozygous state in several individuals affected with late onset Parkinson's disease (PMID: 15596610, 16755580, 19351622, 22243833, 24660942, 27094865). ClinVar contains an entry for this variant (Variation ID: 447942). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PINK1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 31, 2022 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Feb 03, 2017 | - - |
PINK1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 30, 2024 | The PINK1 c.952A>T variant is predicted to result in the amino acid substitution p.Met318Leu. This variant has been reported in the heterozygous state in multiple individuals with both late- and early-onset Parkinson's disease (Rogaeva et al. 2004. PubMed ID: 15596610; Djarmati et al. 2006. PubMed ID: 16755580; Brooks et al. 2009. PubMed ID: 19351622; Pihlstrøm et al. 2014. PubMed ID: 24660942; Bandrés-Ciga et al. 2016. PubMed ID: 27393345; Kuzkina et al. 2022. PubMed ID: 37248217). In vitro functional studies have shown that this variant leads to a loss of PINK1 phosphorylation activity (Broadway et al. 2022. PubMed ID: 35954270). This variant is reported in 0.25% of alleles in individuals of Ashkenazi Jewish descent in gnomAD, including one homozygote. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Pathogenic
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Pathogenic
D
Sift4G
Uncertain
D
Polyphen
B
Vest4
MutPred
Gain of methylation at K319 (P = 0.0356);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at